top of page
GenVisc 850 (Hyaluronic Acid regimen)
GenVisc 850 (sodium hyaluronate) is a sterile medication that is injected into the knees to treat knee pain caused by osteoarthritis in patients who did not achieve adequate relief from conservative treatment or simple pain relievers. Fact Table Formula (C14H21NO11)n License US FDA Bioavailability Poor Legal status OTC Chemical Name Hyaluronic acid Elimination half-life 17 hours to 1.5 days Dosage (Strength) 25mg Pregnancy No Known Risk Brands GenVisc850 Protein binding - PubChem CID 24759 MedlinePlus - ChEBI 16336 ATC code D03AX05 DrugBank DB08818 KEGG D08043 Routes of administration Injection

GenVisc 850 (Hyaluronic Acid regimen)

  • GenVisc 850 is available in 3 mL pre-filled syringes. Each syringe is for single use only and should be used immediately after opening the packaging. The contents of the syringe are injected into the intra-articular space of the knee joint and any remainder should be discarded. If you have any questions, talk to your doctor or pharmacist.
bottom of page